Comments on 2019 Chinese practice guideline for the prevention and treatment of hepatitis B virus mother-to-child transmission
10.3760/cma.j.issn.1007-3418.2020.01.007
- VernacularTitle: 对中国乙型肝炎病毒母婴传播防治指南（2019年版）的商榷
- Author:
Yihua ZHOU
1
;
Tong LI
2
;
Hui ZHUANG
2
Author Information
1. Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing 210008, China
2. Department of Microbiology and Center of Infectious Diseases, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China
- Publication Type:Journal Article
- Keywords:
Hepatitis B virus;
Hepatitis B vaccines;
Antiviral agents;
Blocking mother-to-child transmission;
Hepatitis B immunoglobulin
- From:
Chinese Journal of Hepatology
2020;28(1):24-26
- CountryChina
- Language:Chinese
-
Abstract:
Recently, the Society of Infectious Diseases of Chinese Medical Association and Chinese GRADE Center jointly released the "2019 Chinese practice guideline for the prevention and treatment of hepatitis B virus mother-to-child transmission" . We concerned several issues in the Guideline, including the improper citation of some references, no recommendations for some key strategies for the prevention of hepatitis B virus mother-to-child transmission, insufficient or even lack of evidence for some recommendations and others. Based on the principle of academic contention, we present in this article our comments on the Guideline to discuss these issues with the Guideline’s authors and readers.
